CytoDyn Inc.
USD0.25
+0.00 (+1.30%)
CEO
Jacob Lalezari
IPO Date
2006-12-13
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.25
Prev. Close
$0.25
Day Low
$0.23
Day High
$0.26
52W Low
$0.21
52W High
$0.40
Market Cap
$0.34B
Volume
1.11M
| -3.1 |
| 31 May 2023 | FY | 0.0% | 0.0% | 72.9% | -706.9% | -0.32 | 0.09 | -2.7 |
| 31 May 2022 | FY | 80.1% | -79255.6% | 223.3% | -722.4% | -0.39 | 0.23 | -1.1 |
| 31 May 2021 | FY | 0.0% | 0.0% | 827.9% | -131.8% | -3.02 | 0.85 | -6.9 |
| 31 May 2020 | FY | 0.0% | 0.0% | 5641.5% | -277.0% | -6.19 | 0.83 | -8.9 |
| 31 May 2019 | FY | 0.0% | 0.0% | 630.3% | -269.2% | -0.92 | 0.20 | -1.9 |
| 31 May 2018 | FY | 0.0% | 0.0% | 381.1% | -1023.7% | 0.00 | 0.20 | -1.7 |
| 31 May 2017 | FY | 0.0% | 0.0% | 2335.3% | -319.8% | -0.96 | 1.00 | -3.2 |
| 31 May 2016 | FY | 0.0% | 0.0% | -251.9% | -186.4% | 0.00 | 3.21 | -3.7 |
| -4.6 |
| 31 Aug 2025 | Q1 | 0.0% | 0.0% | 5.6% | -41.1% | -0.44 | 0.19 | -17.0 |
| 31 May 2025 | Q4 | 0.1% | 100.7% | 6.2% | -33.0% | -0.28 | 0.25 | -17.8 |
| 28 Feb 2025 | Q3 | 0.0% | 0.0% | 5.1% | -22.5% | -0.29 | 0.30 | -19.8 |
| 30 Nov 2024 | Q2 | 0.0% | 0.0% | 5.3% | -19.2% | -0.52 | 0.35 | -7.4 |
| 31 Aug 2024 | Q1 | 0.0% | 0.0% | -22.6% | 68.6% | -0.34 | 0.40 | 2.2 |
| 31 May 2024 | Q4 | -8.0% | -33574.0% | 14.4% | -150.7% | -0.26 | 0.13 | -2.4 |
| 29 Feb 2024 | Q3 | 0.0% | 0.0% | 10.0% | -116.1% | -0.26 | 0.08 | -5.3 |
| 30 Nov 2023 | Q2 | 0.0% | 0.0% | 8.4% | -103.5% | -0.29 | 0.07 | -4.3 |